{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:15:56Z","timestamp":1760782556446},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.jcv.2003.11.003","type":"journal-article","created":{"date-parts":[[2004,1,2]],"date-time":"2004-01-02T10:29:21Z","timestamp":1073039361000},"page":"271-275","source":"Crossref","is-referenced-by-count":11,"title":["Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina"],"prefix":"10.1016","volume":"30","author":[{"given":"Silvia","family":"S\u00e1nchez Puch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Carballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Zala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Salom\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Videla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2003.11.003_BIB1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0166-0934(94)00110-3","article-title":"Value of a new rapid non-radioactive sequencing method for analysis of the cytomegalovirus UL97 gene in ganciclovir-resistant strains","volume":"51","author":"Alain","year":"1995","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2003.11.003_BIB2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/172.1.239","article-title":"Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates","volume":"172","author":"Chou","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/171.3.576","article-title":"Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance","volume":"171","author":"Chou","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1399-3062.1999.010204.x","article-title":"Antiviral drug resistance in human cytomegalovirus","volume":"1","author":"Chou","year":"1999","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB5","first-page":"37","article-title":"Changing trends in cytomegalovirus disease in HIV-infected patients","volume":"8","author":"Deayton","year":"2001","journal-title":"Herpes"},{"key":"10.1016\/j.jcv.2003.11.003_BIB6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1386-6532(00)00165-7","article-title":"Progress in understanding cytomegalovirus drug resistance","volume":"21","author":"Emery","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2003.11.003_BIB7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/517467","article-title":"Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral","volume":"178","author":"Erice","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM198902023200505","article-title":"Progressive disease due to ganciclovir resistant cytomegalovirus in immunocompromised patients","volume":"320","author":"Erice","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2003.11.003_BIB9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2003.11.003_BIB10","first-page":"825","article-title":"Cytomegalovirus isolation by conventional cell culture and shell vial assay","volume":"61","author":"Galiano","year":"2001","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.jcv.2003.11.003_BIB11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jcv.2003.11.003_BIB12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3291115","article-title":"The protein kinase family: conserved features and deduced phylogeny of the catalytic domains","volume":"241","author":"Hanks","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jcv.2003.11.003_BIB13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/339603","article-title":"Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis","volume":"185","author":"Hu","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(01)00202-9","article-title":"GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E","volume":"53","author":"Ijichi","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2003.11.003_BIB15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-3542(98)00051-5","article-title":"Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant","volume":"40","author":"Kahan","year":"1998","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2003.11.003_BIB16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2003.11.003_BIB17","first-page":"87","article-title":"Workshop on CMV disease definitions, clinical severity scores, and new syndromes","volume":"99","author":"Ljungman","year":"1995","journal-title":"Scand. J. Infect. Dis. Suppl."},{"key":"10.1016\/j.jcv.2003.11.003_BIB18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB19","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/AAC.45.10.2775-2780.2001","article-title":"Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing","volume":"45","author":"Lurain","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2003.11.003_BIB20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/314943","article-title":"Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy","volume":"180","author":"O\u2019Sullivan","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1086\/319225","article-title":"Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients","volume":"32","author":"Singh","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.jcv.2003.11.003_BIB22","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1093\/clinids\/21.Supplement_2.S170","article-title":"Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens","volume":"21","author":"Spector","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2003.11.003_BIB23","first-page":"25","article-title":"The cytomegalovirus antigenemia assay: a plea for standardization","volume":"99","author":"The","year":"1995","journal-title":"Scand. J. Infect. Dis. Suppl."},{"key":"10.1016\/j.jcv.2003.11.003_BIB24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000150568","article-title":"Treatment of Cytomegalovirus Disease","volume":"40","author":"Uwe-Vogel","year":"1997","journal-title":"Intervirology"},{"key":"10.1016\/j.jcv.2003.11.003_BIB25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI117648","article-title":"Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma","volume":"95","author":"Wolf","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcv.2003.11.003_BIB26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.45.2.593-595.2001","article-title":"Emergence of multiple human cytomegalovirus ganciclovir resistant mutants with deletions and substitutions within the UL97 gene in patient with severe combined immunodeficiency","volume":"45","author":"Wolf","year":"2001","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653203003019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653203003019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T16:39:00Z","timestamp":1585413540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653203003019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1386653203003019"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2003.11.003","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}